CC BY-NC-ND 4.0 · J Lab Physicians 2020; 12(02): 092-097
DOI: 10.1055/s-0040-1716593
Original Article

Genetic Diversity of Human Immunodeficiency Virus Type 1 in Asymptomatic Blood Donors in Islamabad, Pakistan

Usman Waheed
1   Department of Pathology and Transfusion Medicine, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan
2   Islamabad Blood Transfusion Authority, Ministry of National Health Services, Government of Pakistan, Islamabad, Pakistan
,
Farooq Ahmed Noor
3   Department of Pathology and Transfusion Medicine, Divisional Headquarters Teaching Hospital, Mirpur, Azad Jammu and Kashmir, Pakistan
,
Noore Saba
4   Department of Health, Peshawar Regional Blood Centre, Khyber Pakhtunkhwa, Pakistan
,
Akhlaaq Wazeer
3   Department of Pathology and Transfusion Medicine, Divisional Headquarters Teaching Hospital, Mirpur, Azad Jammu and Kashmir, Pakistan
,
Zahida Qasim
3   Department of Pathology and Transfusion Medicine, Divisional Headquarters Teaching Hospital, Mirpur, Azad Jammu and Kashmir, Pakistan
,
Muhammad Arshad
5   Department of Biological Sciences, International Islamic University, Islamabad, Pakistan
,
Saira Karimi
6   Department of Biosciences, COMSATS University, Islamabad, Pakistan
,
Ahmad Farooq
5   Department of Biological Sciences, International Islamic University, Islamabad, Pakistan
,
Javaid Usman
7   Department of Pathology, Army Medical College, National University of Medical Sciences, Rawalpindi, Pakistan
,
Hasan Abbas Zaheer
1   Department of Pathology and Transfusion Medicine, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan
8   Safe Blood Transfusion Programme, Ministry of National Health Services, Government of Pakistan, Islamabad, Pakistan
› Institutsangaben

Abstract

Objective The serological testing of human immunodeficiency virus (HIV) is mandatory under the blood safety legislation of Pakistan; hence, data exist on the prevalence of HIV in blood donors. However, little is known about the molecular epidemiology of HIV in the blood donor population. Therefore, the current study was designed to study the genetic diversity of HIV-1 infection in a population of apparently healthy treatment-naive blood donors in Islamabad, Pakistan.

Material and Methods A total of 85,736 blood donors were tested for HIV by the chemiluminescence immunoassay. All positive donor samples were analyzed for the presence of various HIV genotypes (types and subtypes). Viral ribonucleic acid was extracted from blood samples of HIV positive donors and reverse transcribed into complementary deoxyribonucleic acid (cDNA). The cDNA of all positive donors was then analyzed for the presence of various HIV genotypes (types and subtypes) by employing subtype-specific primers in a nested polymerase chain reaction. The amplified products were run on ethidium bromide-stained 2% agarose gel and visualized using a ultraviolet transilluminator. A particular subtype was assigned to a sample if the subtype-specific reaction made a band 20% highly intense compared with the band made by the subtype-independent reaction.

Results A total of 85,736 blood donors were screened for the presence of antibodies to HIV. Out of them, 114 were initially found reactive for HIV. The repeat testing resulted in 112 (0.13%) positive donors, 95% confidence interval 0.0014 (0.0011–0.0018). These 112 samples were analyzed for molecular typing of HIV-1. The predominant HIV-1 subtype was A (n = 101) (90.1%) followed by subtype B (n = 11) (9.9%).

Conclusion These findings are key to understand the diversified HIV epidemic at the molecular level and should assist public health workers in implementing measures to lessen the further dissemination of these viruses in the country.



Publikationsverlauf

Artikel online veröffentlicht:
02. September 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Parikh UM, McCormick K, van Zyl G, Mellors JW. Future technologies for monitoring HIV drug resistance and cure. Curr Opin HIV AIDS 2017; 12 (02) 182-189
  • 2 Albarillo F, O’Keefe P. Opportunistic neurologic infections in patients with acquired immunodeficiency syndrome (AIDS). Curr Neurol Neurosci Rep 2016; 16 (01) 10
  • 3 Faria NR, Rambaut A, Suchard MA. et al. HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations. Science 2014; 346 (6205) 56-61
  • 4 German Advisory Committee Blood (Arbeitskreis Blut), Subgroup ‘Assessment of Pathogens Transmissible by Blood’. Human immunodeficiency virus (HIV). Transfus Med Hemother 2016; 43 (03) 203-222
  • 5 Gao F, Bailes E, Robertson DL. et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999; 397 (6718) 436-441
  • 6 Nyamweya S, Hegedus A, Jaye A, Rowland-Jones S, Flanagan KL, Macallan DC. Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis. Rev Med Virol 2013; 23 (04) 221-240
  • 7 World Health Organization. Fact Sheet HIV/AIDS 2019. Available at: https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Accessed September 27, 2019
  • 8 Bokhari A, Nizamani NM, Jackson DJ. et al. HIV risk in Karachi and Lahore, Pakistan: an emerging epidemic in injecting and commercial sex networks. Int J STD AIDS 2007; 18 (07) 486-492
  • 9 Emmanuel F, Salim M, Akhtar N, Arshad S, Reza TE. -generation surveillance for HIV/AIDS in Pakistan: results from the 4th round of Integrated Behavior and Biological Survey 2011-2012. Sex Transm Infect 2013; 89 (03) (Suppl. 03) iii23-iii28
  • 10 National AIDS Control Programme, Government of Pakistan. Available at: https://www.nacp.gov.pk/. Accessed December 27, 2019
  • 11 Abu-Raddad LJ, Hilmi N, Mumtaz G. et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS 2010; 24 (02) (Suppl. 02) S5-S23
  • 12 Khan S, Rai MA, Khanani MR, Khan MN, Ali SH. HIV-1 subtype A infection in a community of intravenous drug users in Pakistan. BMC Infect Dis 2006; 6: 164
  • 13 Khanani MR, Somani M, Rehmani SS, Veras NMC, Salemi M, Ali SH. The spread of HIV in Pakistan: bridging of the epidemic between populations. PLoS One 2011; 6 (07) e22449
  • 14 Chen Y, Hora B, DeMarco T. et al. Fast dissemination of new HIV-1 CRF02/A1 recombinants in Pakistan. PLoS One 2016; 11 (12) e0167839
  • 15 World Health Organization. Fact Sheet on blood safety and availability. Available at: https://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability. Accessed September 27, 2019
  • 16 Ammann AJ, Cowan MJ, Wara DW. et al. Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet 1983; 1 (8331) 956-958
  • 17 Waheed U, Arshad M, Usman J, Farooq A, Wazeer A, Zaheer HA. Surveillance of human immunodeficiency virus in blood donors of Islamabad, Pakistan: a meta-analysis. Pak Armed Forces Med J 2017; 67 (05) 860-867
  • 18 Zaheer HA, Ahmed S, Waheed U, Wazeer A. National Guidelines for Quality Control in Transfusion Medicine. 2nd ed. Islamabad: SBTP, Ministry of National Health Services, Pakistan; 2020:49–56. Available at: https://www.sbtp.gov.pk/wp-content/uploads/2020/03/National-Guidelines-Quality-Control-in-Transfusion-Medicine-2020.pdf. Accessed January 27, 2020
  • 19 Kato S, Saito R, Hiraishi Y. et al. Differential prevalence of HIV type 1 subtype B and CRF01_AE among different sexual transmission groups in Tokyo, Japan, as revealed by subtype-specific PCR. AIDS Res Hum Retroviruses 2003; 19 (11) 1057-1063
  • 20 Abrar N, Ghouri AM. AIDS/HIV knowledge, attitude and beliefs of adolescents of Pakistan. Eur J Soil Sci 2016; 16 (02) 275-285
  • 21 Waheed U, Zaheer HA. Possible transmission of human immunodeficiency virus through blood transfusion in Pakistan. Glob J Transfus Med 2019; 4 (01) 117-118
  • 22 Sharew B, Mulu A, Teka B, Tesfaye T. HIV-Sero-prevalence trend among blood donors in North East Ethiopia. Afr Health Sci 2017; 17 (03) 712-718
  • 23 Shrestha AC, Ghimire P, Tiwari BR, Rajkarnikar M. Transfusion-transmissible infections among blood donors in Kathmandu, Nepal. J Infect Dev Ctries 2009; 3 (10) 794-797
  • 24 Song Y, Bian Y, Petzold M, Ung COL. Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010. PLoS One 2014; 9 (04) e94528
  • 25 Sube KL, Serianoa OF, Gorea RP. et al. The prevalence of HIV among blood donors at Juba Teaching Hospital Blood Bank, South Sudan. South Sudan Med J 2014; 7 (04) 76-80
  • 26 Hassan A, Muktar HM, Mamman AI, Ahmed AJ, Isa AH, Babadoko AA. The incidence of HIV among blood donors in Kaduna, Nigeria. Afr Health Sci 2007; 7 (04) 253
  • 27 Tessema B, Yismaw G, Kassu A. et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis 2010; 10: 111
  • 28 Nagalo MB, Sanou M, Bisseye C. et al. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus 2011; 9 (04) 419-424
  • 29 Ahmed Z, Umaru N, Shreesha K. Seroprevalence of transfusion transmitted infections among blood donors in Mangalore. Journal of Medical Innovates 2012; 1 (02) 24-27
  • 30 Mohsenizadeh M, Mollaei HR, Ghaziizadeh M. Seroepidemiological study of hepatitis B, C and HIV among blood donors in Kerman. Asian Pac J Cancer Prev 2017; 18 (12) 3267-3272
  • 31 Gonzalez M, Règine V, Piccinini V, Vulcano F, Giampaolo A, Hassan HJ. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Transfusion 2005; 45 (10) 1670-1675
  • 32 Polizzotto MN, Wood EM, Ingham H, Keller AJ. Australian Red Cross Blood Service Donor and Product Safety Team. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion 2008; 48 (01) 55-63
  • 33 Woodman Z, Williamson C. HIV molecular epidemiology: transmission and adaptation to human populations. Curr Opin HIV AIDS 2009; 4 (04) 247-252
  • 34 Lau KA, Wong JJ. Current trends of HIV recombination worldwide. Infect Dis Rep 2013; 5 (Suppl. 01) e4
  • 35 Yamaguchi J, Vallari A, McArthur C. et al. Brief report: complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L. J Acquir Immune Defic Syndr 2020; 83 (03) 319-322
  • 36 Hemelaar J, Gouws E, Ghys PD, Osmanov S. WHO-UNAIDS Network for HIV Isolation and Characterisation. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011; 25 (05) 679-689
  • 37 Los Alamos National Laboratory. HIV databases. Available at: https://www.hiv.lanl.gov/content/index. Accessed November 27, 2019
  • 38 Khanani RM, Hafeez A, Rab SM, Rasheed S. Human immunodeficiency virus-associated disorders in Pakistan. AIDS Res Hum Retroviruses 1988; 4 (02) 149-154
  • 39 Shah SA, Khan OA, Kristensen S, Vermund SH. HIV-infected workers deported from the Gulf States: impact on Southern Pakistan. J Pak Med Assoc 2006; 56 (01) (Suppl. 01) S22-S24